Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Samus Therapeutics, Inc.
Tocagen Inc.
Novartis
University of South Florida
Children's Hospital Medical Center, Cincinnati
Case Comprehensive Cancer Center